Renub Research Page 2 of 16

United States Pediatric Vaccines Market Analysis

Pediatric Vaccines market for United States is a multi-billion dollar industry. The value of

United States pediatric vaccines market alone is expected to reach more than US$ 18 Billion

by 2020. The United States Pediatric vaccines market is driven by favorable demographics,

growing public acceptance and product innovation. Varicella and Pneumococcal vaccines

(PCV) control the highest and second highest market share in United States respectively.

Together both of these vaccines control more than 50% market share.

In number of cases Polio, MMR, Diphtheria and Tetanus cases have diminished significantly

from the year 2001 till 2013. In United States, DTP are the highly penetrated vaccines in

pediatric vaccines market which contributed more than 100 Million doses in 2014. Polio and

MMR are also mostly used vaccines together they consumed more than 150 Million doses in

2014. It is predicted that these three vaccines will bolster the usable pattern in the United

States.

The United States pediatric vaccines are expected to remain highly active in the future,

fueled by the encouragement and financing from Governments and other health

organizations.

This is 8th edition report on Vaccines Market & 3rd edition on Pediatric Vaccines Market by

Renub Research. Report titled " United States Pediatric Vaccines Market, Doses,

Immunization (Vaccinated), Cases & Forecast talks about the pediatric vaccines. The

report provides information on all the Ten (10) Pediatric Vaccines Market, Doses, Number of

Children Being Vaccinated and Number of Cases in United States. This report covers in detail

all aspects of past, present and future scenario. The report also entails major factors driving

the Pediatric vaccines market and challenges of Pediatric vaccines market.

Ten (10) Pediatric Vaccines Covered in this Report are as follows:

1. Measles, Mumps & Rubella (MMR) Vaccines

2. Haemophilus Influenzae Type B (HIB) Vaccines

3. Polio Vaccines

4. Diphtheria Tetanus & Pertussis (DTaP) Vaccines

Renub Research Page 3 of 16

5. Pneumococcal Vaccines

6. Rotavirus Vaccines

7. Hepatitis B Pediatric Vaccines

8. Hepatitis A Pediatric Vaccines

9. Varicella / Chicken Pox Vaccines

10. Influenza Pediatric Vaccines

All the Pediatric Vaccines in this Report have been studied from Four View Points:

1. Number of Cases

2. Number of Doses

3. Number of Children Being Vaccinated

4. Market Size for all 10 Pediatric Vaccines

Key Topics Covered in the Report

United States Pediatric Vaccines Market & Forecast

United States Pediatric Vaccines Market Share & Forecast

United States - Pediatric Disease Cases

Pediatric Vaccines Doses and Forecast

Number of Children Being Vaccinated

Market Size for all 10 Pediatric Vaccines

Growth Drivers of Pediatric Vaccines Market

Challenges of Pediatric Vaccines Market

Renub Research Page 4 of 16

Data Sources

This report is built using data and information sourced from proprietary databases, primary

and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-

printable sources like search engines, News websites, Government Websites, Trade Journals,

White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books,

Industry Portals, Industry Associations and access to more than 500 paid databases.

Renub Research Page 5 of 16

About Us

RReennuubb RReesseeaarrcchh is a leading Market Research and Information Analysis Company with

centers at Noida India and Roswell USA. We have long-term experience especially in

international Business-to-Business Researches, Surveys, Business and Consulting. Throughout

the years we have acquired expertise in most market sectors, including Information

Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services

(Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG,

Consumer Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and

Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information

Technology, Environmental Science and many more. Our research help make the business

decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We

support many blue chip companies by providing them findings and perspectives across a wide

range of markets. Our research reports offer a blend of information insight, analysis and

forecasting that is essential in todays ultra-competitive markets.

For more information on us or to view any of our sample work you can

mail us at info@renub.com

Renub Research Page 6 of 16

Published

By

RReennuubb RReesseeaarrcchh

1st Floor

C 86, Sector 10

Noida 201301

Phone: +911204219822, 2545750 (India)

+16783020700 (USA)

Fax : +911204249780

Email: info@renub.com

www.renub.com

United States Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases &

Forecast

Renub Research, 2015

Edition 3.0

All rights reserved. This publication is protected

by copyright. No part of it may be reproduced, stored

in a retrieval system or transmitted, in any form or by

any means, electronic mechanical, photocopying,

recording or otherwise without the prior written

permission of the publishers

Renub Research Page 7 of 16

Table of Contents

1. Executive Summary

2. United States Pediatric Vaccines Market & Forecast

3. United States Pediatric Vaccines Market Share & Forecast

4. United States Pediatric Vaccines Cases, Doses, Immunization Coverage, Market & Forecast

4.1 United States Measles, Mumps & Rubella (MMR) Vaccines & Forecast

4.1.1 Number of Measles, Mumps & Rubella (MMR) Cases

4.1.2 Number of Measles, Mumps & Rubella (MMR) Vaccines Doses

4.1.3 Measles, Mumps & Rubella (MMR) Number of Children Being Vaccinated

4.1.4 Market Size of Measles, Mumps & Rubella (MMR) Vaccines

4.2 United States Haemophilus Influenzae Type B (HIB) Vaccines & Forecast

4.2.1 Number of Haemophilus Influenzae Type B (HIB) Vaccines Doses

4.2.2 Haemophilus Influenzae Type B (HIB) Number of Children Being Vaccinated

4.2.3 Market Size of Haemophilus Influenzae Type B (HIB) Vaccines

4.3 United States Polio Vaccines & Forecast

4.3.1 Number of Polio Cases

4.3.2 Number of Polio Vaccines Doses

4.3.3 Polio Vaccines Number of Children Being Vaccinated

4.3.4 Market Size of Polio Vaccines

4.4 United States Diphtheria, Tetanus & Pertussis (DTap) Vaccines & Forecast

4.4.1 Number of Diphtheria, Tetanus & Pertussis (DTaP) Cases

4.4.2 Number of Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Doses

4.4.3 Diphtheria, Tetanus & Pertusis (DTaP) Number of Children Being Vaccinated

4.4.4 Market Size of Diphtheria, Tetanus & Pertussis (DTaP) Vaccines

4.5 United States Pneumococcal Vaccines & Forecast

4.5.1 Number of Pneumococcal Vaccines Doses

4.5.2 Pneumococcal Number of Children Being Vaccinated

4.5.3 Market Size of Pneumococcal Vaccines

4.6 United States Rotavirus Vaccines & Forecast

4.6.1 Number of Rotavirus Vaccines Doses

4.6.2 Rotavirus Number of Children Being Vaccinated

4.6.3 Market Size of Rotavirus Vaccine

Renub Research Page 8 of 16

4.7 United States Hepatitis B Pediatric Vaccines & Forecast

4.7.1 Number of Hepatitis B Pediatric Vaccines Doses

4.7.2 Hepatitis B Pediatric Number of Children Being Vaccinated

4.7.3 Market Size of Hepatitis B Pediatric Vaccines

4.8 United States Hepatitis A Pediatric Vaccines & Forecast

4.8.1 Number of Hepatitis A Pediatric Vaccines Doses

4.8.2 Hepatitis A Pediatric Number of Children Being Vaccinated & Forecast

4.8.3 Market Size of Hepatitis A Pediatric Vaccines

4.9 United States Varicella / Chicken Pox Vaccines & Forecast

4.9.1 Number of Varicella / Chicken Pox Vaccines Doses

4.9.2 Varicella/Chicken Pox Number of Children Being Vaccinated

4.9.3 Market Size of Varicella/Chicken Pox Vaccines

4.10 United States Influenza Pediatric Vaccines & Forecast

4.10.1 Number of Influenza Pediatric Vaccines Doses

4.10.2 Influenza Pediatric Vaccines Number of Children Being Vaccinated

4.10.3 Market Size of Influenza Pediatric Vaccines

5. Growth Drivers of United States Pediatric Vaccines Market

5.1 Increase Immunization Rates & Reduce Preventable Infectious Diseases

5.2 Increasing Vaccine Availability in United States

5.3 The Vaccine Safety Data link Project

5.4 The Vaccine Injury Compensation Program

5.5 Transforming of Vaccine Technologies

5.6 Continuous Focus on Effective Communication Strategies

6. Challenges of United States Pediatric Vaccines Market

6.1 Impediment in Pediatric Vaccine Research & Development

6.2 Barriers to New Entrants in the Pediatric Vaccines Market

6.3 Hurdles to Optimal use of Licensed Vaccines

6.3.1 Technical Obstacles

6.3.2 Economic obstacles

6.3.3 Cultural Obstacles

6.4 Complexity of Vaccine Development & Approval System Thwarts Product Development

6.4.1 Legal Obstacles

Renub Research Page 9 of 16

6.4.2 General Technical Barriers

6.4.3 Economic Barriers

6.4.4 Regulatory Barriers

6.5 Shortening the Timeline for Vaccine Development

6.6 Refusal / Resistance to Vaccination

6.6.1 Vaccine Adverse Event Reporting System

6.7 Vaccine Shortages and Delays

6.8 Emerging Issues in Immunization and Infectious Diseases in United States

Renub Research Page 10 of 16

List of Figures

Figure 2-1: United States Pediatric Vaccines Market (Million US$), 2010 2014

Figure 2-2: United States Forecast for Pediatric Vaccines Market (Million US$), 2015 2020

Figure 3-1: United States Pediatric Vaccines Market Share (Percent), 2010 2014

Figure 3-2: United States Forecast for Pediatric Vaccines Market Share (Percent), 2015 2020

Figure 4-1: United States Number of MMR Vaccines Doses (Million Doses), 2010 2014

Figure 4-2: United States Forecast for Number of MMR Vaccines Doses (Million Doses), 2015 2020.

Figure 4-3: United States Number of Children Being Vaccinated with MMR Vaccines (Million), 2010

2014

Figure 4-4: United States Forecast for Number of Children Being Vaccinated with MMR Vaccines

(Million), 2015 2020

Figure 4-5: United States Measles, Mumps & Rubella Vaccines Market (Million US$), 2010 2014

Figure 4-6: United States Forecast for Measles, Mumps & Rubella Vaccines Market (Million US$), 2015

2020

Figure 4-7: United States Number of Doses of Haemophilus Influenzae Type B Vaccines (Million

Doses), 2010 2014

Figure 4-8: United States Forecast for Number of Doses of Haemophilus Influenzae Type B Vaccines

(Million Doses), 2015 2020

Figure 4-9: United States Number of Children Being Vaccinated with Haemophilus Influenzae Type B

Vaccines (Million), 2010 2014

Figure 4-10: United States Number of Children Being Vaccinated with Haemophilus Influenzae Type B

Vaccines (Million), 2015 2020

Figure 4-11: United States Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2010

2014

Figure 4-12: United States Forecast for Haemophilus Influenzae Type B (HIB) Vaccines Market (Million

US$), 2015 2020

Figure 4-14: United States Number of Doses of Polio Vaccines (Million Doses), 2010 2014

Figure 4-15: United States Forecast for Number of Doses of Polio Vaccines (Million Doses), 2015

2020

Figure 4-16: United States Number of Children Being Vaccinated with Polio Vaccines (Million), 2010

2014

Figure 4-17: United States Forecast for Number of Children Being Vaccinated with Polio Vaccines

(Million), 2015 2020

Figure 4-18: United States Polio Vaccines Market (Million US$), 2010 2014

Figure 4-19: United States Forecast for Polio Vaccines Market (Million US$), 2015 2020

Figure 4-20: United States Number of Doses of DTaP Vaccines (Million Doses), 2010 2014

Renub Research Page 11 of 16

Figure 4-21: United States Forecast for Number of Doses of DTaP Vaccines (Million Doses), 2015

2020

Figure 4-22: United States Number of Children Being Vaccinated with DTaP Vaccines (Million), 2010

2014

Figure 4-23: United States Forecast for Number of Children Being Vaccinated with DTaP Vaccines

(Million), 2015 2020

Figure 4-24: United States Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Market (Million US$), 2010

2014

Figure 4-25: United States Forecast for Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Market

(Million US$), 2015 2020

Figure 4-26: Worldwide Pneumococcal Vaccine Pipeline, 2000 2025

Figure 4-27: United States Number of Doses of Pneumococcal Vaccines (Million Doses), 2010 2014

Figure 4-28: United States Forecast for Number of Doses of Pneumococcal Vaccines (Million Doses),

2015 2020

Figure 4-29: United States Number of Children Being Vaccinated with Pneumococcal Vaccines

(Million), 2010 2014

Figure 4-30: United States Forecast for Number of Children Being Vaccinated with Pneumococcal

Vaccines (Million), 2015 2020

Figure 4-31: United States Pneumococcal Vaccines Market (Million US$), 2010 2014

Figure 4-32: United States Forecast for Pneumococcal Vaccines Market (Million US$), 2015 2020

Figure 4-33: United States Number of Doses of Rotavirus Vaccines (Million Doses), 2010 2014

Figure 4-34: United States Forecast for Number of Doses of Rotavirus Vaccines (Million Doses), 2015

2020

Figure 4-35: United States Number of Children Being Vaccinated with Rotavirus Vaccines (Million),

2010 2014

Figure 4-36: United States Forecast for Number of Children Being Vaccinated with Rotavirus Vaccines

(Million), 2015 2020

Figure 4-37: United States Rotavirus Vaccines Market (Million US$), 2010 2014

Figure 4-38: United States Forecast for Rotavirus Vaccines Market (Million US$), 2015 2020

Figure 4-39: United States Number of Doses of Hepatitis B Pediatric Vaccines (Million Doses), 2010

2014

Figure 4-40: United States Forecast for Number of Doses of Hepatitis B Pediatric Vaccines (Million

Doses), 2015 2020

Figure 4-41: United States Number of Children Being Vaccinated with Hepatitis B Pediatric Vaccines

(Million), 2010 2014

Figure 4-42: United States Number of Children Being Vaccinated with Hepatitis B Pediatric Vaccines

(Million), 2015 2020

Renub Research Page 12 of 16

Figure 4-43: United States Hepatitis B Pediatric Vaccines Market (Million US$), 2010 2014

Figure 4-44: United States Forecast for Hepatitis B Pediatric Vaccines Market (Million US$), 2015

2020

Figure 4-45: United States Number of Doses of Hepatitis A Pediatric Vaccines (Million Doses), 2010

2014

Figure 4-46: United States Forecast for Number of Doses of Hepatitis A Pediatric Vaccines (Million

Doses), 2015 2020

Figure 4-47: United States Number of Children Being Vaccinated with Hepatitis A Pediatric Vaccines

(Million), 2010 2014

Figure 4-48: United States Forecast for Number of Children Being Vaccinated with Hepatitis A Pediatric

Vaccines (Million), 2015 2020

Figure 4-49: United States Hepatitis A Pediatric Vaccines Market (Million US$), 2010 2014

Figure 4-50: United States Forecast for Hepatitis A Pediatric Vaccines Market (Million US$), 2015

2020

Figure 4-51: United States Number of Doses of Varicella Vaccines (Million Doses), 2010 2014

Figure 4-52: United States Forecast for Number of Doses of Varicella Vaccines (Million Doses), 2015

2020

Figure 4-53: United States Number of Children Being Vaccinated with Varicella Vaccines (Million), 2010

2014

Figure 4-54: United States Forecast for Number of Children Being Vaccinated with Varicella Vaccines

(Million), 2015 2020

Figure 4-55: United States Varicella Vaccines Market (Million US$), 2010 2014

Figure 4-56: United States Forecast for Varicella Vaccines Market (Million US$), 2015 2020

Figure 4-57: United States Number of Influenza Pediatric Vaccines Doses (Million Doses), 2010 2014

Figure 4-58: United States Forecast for Number of Influenza Pediatric Vaccines Doses (Million Doses),

2015 2020

Figure 4-59: United States Number of Children Being Vaccinated with Influenza Pediatric Vaccines

(Million), 2010 2014

Figure 4-60: United States Forecast for Number of Children Being Vaccinated with Influenza Pediatric

Vaccines (Million), 2015 2020

Figure 4-61: United States Influenza Pediatric Vaccines Market (Million US$), 2010 2014

Figure 4-62: United States Forecast for Influenza Pediatric Vaccines Market (Million US$), 2015 2020

Figure 5-1: United States Number of Retail Clinics offering Vaccination (Number), 2007 2012

Renub Research Page 13 of 16

List of Tables

Table 4-1: United States Number of Measles Cases (Number), 1999 2013

Table 4-2: United States Number of Mumps Cases (Number), 1999 2013

Table 4-3: United States Number of Rubella Cases (Number), 1999 2013

Table 4-4: United States Number of Polio Cases (Number), 2001 2013

Table 4-5: United States Number of Diphtheria Cases (Number), 1999 2013

Table 4-6: United States Number of nTetanus Cases (Number), 1999 2013

Table 4-7: United States Number of tTetanus Cases (Number), 1999 2013

Table 4-8: United States Number of Pertussis Cases (Number), 1999 2013

Table 5-1: Improvement Strategies or Requirements the Joint Commission and the Projects

Collaborating Organizations

Renub Research Page 14 of 16

Order Form

Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact

Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780

Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to

info@renub.com

Format

Report Title: United States Pediatric Vaccines Market, Doses, Immunization (Vaccinated),

Cases & Forecast

Single User (Email from Publisher)

Hard Copy (Mail Delivery)

CD Rom (Mail Delivery)

Global Site License (Multiple User License)

US$ 1,100 US$ 1,200 US$ 1,200 US$ 1,900

For ordering this report: Three easy ways to place your order:

1) Order online by Credit Card (Visa, MasterCard, etc.):

http://www.renub.com/report/united-states-pediatric-vaccines-market-doses-immunization-

vaccinated-cases-forecast-165

2) Order by Wire Transfer:

http://www.renub.com/report/wiretransfer.aspx?id=165&pid=1633

To pay by Wire Transfer, please, fill in your contact details in the form below:

Renub Research Page 15 of 16

Bank Details

Account Name: Renub Research

A/C No.: 109102000023296

Name of Bank: IDBI Bank Ltd.

Swift Code: IBKLINBB010

Bank Address: 4th Floor

Indian Red Cross Building

1 Red Cross Road

Opposite Parliament Street

New Delhi 110001

India

Contact Information

First Name: Last Name:

Email:

Job Title:

Company:

Address:

City:

Postal/Zip Code:

Country:

Phone:

Mobile:

Fax:

Report Format:

Your message:

Renub Research Page 16 of 16

3) Order by Check

Please post the check accompanied by this form, to:

Company Address: Renub Research

1st Floor

C-86, Sector -10

Noida - 201301

Uttar Pradesh

India

Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at

info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us

Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090

LinkedIn: http://www.linkedin.com/company/renub-research

Twitter: http://twitter.com/RenubResearch